Viemed Healthcare, Inc. $VMD Shares Sold by Hsbc Holdings PLC

Hsbc Holdings PLC reduced its stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 46.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 55,883 shares of the company’s stock after selling 47,686 shares during the quarter. Hsbc Holdings PLC owned about 0.15% of Viemed Healthcare worth $517,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. North Star Investment Management Corp. bought a new position in Viemed Healthcare in the 1st quarter valued at about $921,000. Diversified Trust Co bought a new stake in shares of Viemed Healthcare during the 1st quarter worth about $107,000. Invesco Ltd. lifted its stake in shares of Viemed Healthcare by 17.1% in the 4th quarter. Invesco Ltd. now owns 21,773 shares of the company’s stock worth $162,000 after acquiring an additional 3,173 shares during the period. NewEdge Advisors LLC acquired a new stake in shares of Viemed Healthcare in the 4th quarter worth approximately $174,000. Finally, Millennium Management LLC boosted its holdings in shares of Viemed Healthcare by 348.2% in the fourth quarter. Millennium Management LLC now owns 48,398 shares of the company’s stock valued at $360,000 after acquiring an additional 37,600 shares in the last quarter. Institutional investors and hedge funds own 74.24% of the company’s stock.

Viemed Healthcare Price Performance

NASDAQ:VMD opened at $11.67 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.22 and a debt-to-equity ratio of 0.06. The business’s 50-day moving average price is $11.12 and its 200 day moving average price is $9.65. Viemed Healthcare, Inc. has a 52-week low of $5.93 and a 52-week high of $12.61. The firm has a market cap of $447.43 million, a P/E ratio of 31.54 and a beta of 1.10.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.06 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.03). Viemed Healthcare had a net margin of 5.20% and a return on equity of 10.52%. The business had revenue of $75.41 million during the quarter, compared to analyst estimates of $74.40 million. As a group, sell-side analysts predict that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “hold (c+)” rating on shares of Viemed Healthcare in a report on Friday, July 17th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, Viemed Healthcare presently has an average rating of “Hold”.

Insider Activity at Viemed Healthcare

In other Viemed Healthcare news, Director Timothy Smokoff sold 20,000 shares of the company’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $11.50, for a total value of $230,000.00. Following the transaction, the director owned 75,518 shares of the company’s stock, valued at approximately $868,457. This represents a 20.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider William Frazier sold 10,000 shares of the company’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total value of $117,200.00. Following the completion of the transaction, the insider directly owned 73,214 shares in the company, valued at $858,068.08. This represents a 12.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 20.60% of the stock is owned by corporate insiders.

Viemed Healthcare Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.